TCRαβ-depleted hematopoietic stem cell transplant and third-party CD45RA+ depleted adoptive cell therapy for treatment of post-transplant parvovirus B19 aplastic crisis.

MLA

Zhang, Manpin, et al. “TCRαβ-Depleted Hematopoietic Stem Cell Transplant and Third-Party CD45RA+ Depleted Adoptive Cell Therapy for Treatment of Post-Transplant Parvovirus B19 Aplastic Crisis.” International Journal of Infectious Diseases, vol. 144, July 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ijid.2024.107043.

APA

Zhang, M., Luo, C., Wang, J., Zhu, H., Luo, C., Qin, X., Huang, X., Lin, Y., & Chen, J. (2024). TCRαβ-depleted hematopoietic stem cell transplant and third-party CD45RA+ depleted adoptive cell therapy for treatment of post-transplant parvovirus B19 aplastic crisis. International Journal of Infectious Diseases, 144, N.PAG. https://doi.org/10.1016/j.ijid.2024.107043

Chicago

Zhang, Manpin, Chengjuan Luo, Jianmin Wang, Hua Zhu, Changying Luo, Xia Qin, Xiaohang Huang, Yuchen Lin, and Jing Chen. 2024. “TCRαβ-Depleted Hematopoietic Stem Cell Transplant and Third-Party CD45RA+ Depleted Adoptive Cell Therapy for Treatment of Post-Transplant Parvovirus B19 Aplastic Crisis.” International Journal of Infectious Diseases 144 (July): N.PAG. doi:10.1016/j.ijid.2024.107043.